World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Autolus Therapeutics

    World Rank (Jan-05-2024)
    7,827
    Market Cap (Jan-05-2024)
    1.170 Billion USD
    World Rank (Jul-30-2023)
    12,973
    Market Cap (Jul-30-2023)
    0.483 Billion USD
    World Rank (Dec-25-2022)
    18,558
    Market Cap (Dec-25-2022)
    0.181 Billion USD
    World Rank (Jan-07-2022)
    15,847
    Market Cap (Jan-07-2022)
    0.34 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -142 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    UK
    Yahoo @ Frankfurt
    Company Profile

    Autolus Therapeutics is a Biopharmaceutical company. The headquarters is in UK.

    Company Website
    AUTOLUS THERAPEUTICS PLC

  2. Aim Vaccine Co. Ltd

    World Rank (Jan-05-2024)
    7,829
    Market Cap (Jan-05-2024)
    1.170 Billion USD
    World Rank (Jul-30-2023)
    1,993
    Market Cap (Jul-30-2023)
    8.065 Billion USD
    World Rank (Dec-25-2022)
    3,561
    Market Cap (Dec-25-2022)
    3.608 Billion USD
    Headquarters Country
    China
    Company Profile
    Develops vaccines and headquarters is in China.
    Company Website
    AIM VACCINE CO., LTD.

  3. Cti Biopharma

    World Rank (Jan-05-2024)
    7,854
    World Rank (Jul-30-2023)
    7,854
    Market Cap (Jul-30-2023)
    1.200 Billion USD
    World Rank (Dec-25-2022)
    10,235
    Market Cap (Dec-25-2022)
    0.714 Billion USD
    World Rank (Jan-07-2022)
    18,442
    Market Cap (Jan-07-2022)
    0.22 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -52 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Website
    CTI BIOPHARMA

  4. Kura Oncology

    World Rank (Jan-05-2024)
    7,868
    Market Cap (Jan-05-2024)
    1.161 Billion USD
    World Rank (Jul-30-2023)
    10,368
    Market Cap (Jul-30-2023)
    0.739 Billion USD
    World Rank (Dec-25-2022)
    9,716
    Market Cap (Dec-25-2022)
    0.781 Billion USD
    World Rank (Jan-07-2022)
    10,231
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -139 Million USD
    Annual Net Income in USD
    -135 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Kura Oncology is a Clinical Stage Biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company total assets is 265.6 million USD and 134 employees as on 2019. The headquarters is in USA.
    Company Website
    KURA ONCOLOGY

  5. Viridian Therapeutics Inc.

    World Rank (Jan-05-2024)
    7,887
    Market Cap (Jan-05-2024)
    1.157 Billion USD
    World Rank (Jul-30-2023)
    10,091
    Market Cap (Jul-30-2023)
    0.775 Billion USD
    World Rank (Dec-25-2022)
    7,533
    Market Cap (Dec-25-2022)
    1.200 Billion USD
    World Rank (Jan-07-2022)
    14,511
    Market Cap (Jan-07-2022)
    0.43 Billion USD
    Headquarters Country
    USA
    Company Website
    VIRIDIAN THERAPEUTICS, INC.

  6. Geron Corporation

    World Rank (Jan-05-2024)
    7,962
    Market Cap (Jan-05-2024)
    1.135 Billion USD
    World Rank (Jul-30-2023)
    6,549
    Market Cap (Jul-30-2023)
    1.618 Billion USD
    World Rank (Dec-25-2022)
    9,612
    Market Cap (Dec-25-2022)
    0.797 Billion USD
    World Rank (Jan-07-2022)
    15,170
    Market Cap (Jan-07-2022)
    0.38 Billion USD
    Annual Revenue in USD
    1 Million USD
    Annual Operating Income in USD
    -138 Million USD
    Annual Net Income in USD
    -141 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Geron Corporation is a Late Stage Clinical Biopharmaceutical company focused on the development and potential commercialization of a first in class telomerase inhibitor, imetelstat, an innovative therapeutic for hematologic myeloid malignancies. The headquarters is in USA.

    Facts About Company

    Geron Corporation Annual Total Revenue for year ending Dec-2022 was 0.5 million USD and and Net loss for year ending Dec-2022 was -141 million USD.

    Geron Corporation Annual Total Revenue for year ending Dec-2021 was 1.3 million USD and and Net loss for year ending Dec-2021 was =116 million USD.

    As on 2022, Geron Corporation has 107 employees.

    Company Website
    GERON CORPORATION
    Wikipedia
    Wikipedia

  7. Amylyx Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    8,008
    Market Cap (Jan-05-2024)
    1.123 Billion USD
    World Rank (Jul-30-2023)
    6,840
    Market Cap (Jul-30-2023)
    1.514 Billion USD
    World Rank (Dec-25-2022)
    4,858
    Market Cap (Dec-25-2022)
    2.356 Billion USD
    World Rank (Jan-07-2022)
    8,733
    Headquarters Country
    USA
    Company Profile
    Amylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.
    Company Website
    AMYLYX PHARMACEUTICALS, INC.

  9. Soleno Therapeutics

    World Rank (Jan-05-2024)
    8,024
    Market Cap (Jan-05-2024)
    1.119 Billion USD
    World Rank (Jul-30-2023)
    24,771
    Market Cap (Jul-30-2023)
    0.055 Billion USD
    World Rank (Dec-25-2022)
    31,050
    Market Cap (Dec-25-2022)
    0.012 Billion USD
    World Rank (Jan-07-2022)
    27,428
    Market Cap (Jan-07-2022)
    0.04 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -25 Million USD
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    SOLENO THERAPEUTICS

  10. Pliant Therapeutics Inc.

    World Rank (Jan-05-2024)
    8,026
    Market Cap (Jan-05-2024)
    1.119 Billion USD
    World Rank (Jul-30-2023)
    8,672
    Market Cap (Jul-30-2023)
    1.013 Billion USD
    World Rank (Dec-25-2022)
    9,003
    Market Cap (Dec-25-2022)
    0.888 Billion USD
    World Rank (Jan-07-2022)
    13,818
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    10 Million USD
    Annual Operating Income in USD
    -127 Million USD
    Annual Net Income in USD
    -123 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Company Profile
    Pliant Therapeutics is a Clinical Stage Biopharmaceutical company focused on the developing new treatments for fibrotic diseases. The company estimated annual revenue is currently 18.9 million USD per year. The headquarters is in USA.
    Company Website
    PLIANT THERAPEUTICS, INC.

Share